한글목차

음성 바이오마커 세계 시장 규모는 2024년 20억 1,000만 달러로 평가되었고, 2030년까지 연평균 9.32%로 예측 기간 동안 강력한 성장이 예상됩니다.

세계 음성 바이오마커 시장은 음성 분석과 인공지능의 혁신적인 통합으로 헬스케어 및 기술 산업에서 빠르게 부상하고 있는 역동적인 분야입니다. 음성 바이오마커는 목소리에 내재된 풍부한 정보를 활용하여 다양한 질병을 진단, 모니터링, 예측하는 획기적인 개념입니다. 이 시장은 비침습적 특성과 조기 발견 및 개인화된 치료 솔루션을 제공함으로써 헬스케어에 변화를 가져올 수 있는 가능성으로 인해 큰 견인력을 얻고 있습니다. 예를 들어, "Voice as a Biomarker in Health-Tech(Voice as a Biomarker in Health-Tech)"라는 제목의 국립의학도서관(National Library of Medicine)에 게재된 논문에 따르면, 이 시장은 큰 주목을 받고 있다: Mapping the Evolving Landscape of Voice Biomarkers in the Start-Up World"라는 제목의 국립의학도서관에 게재된 논문에 따르면, 음성을 바이오마커로 사용하는 것이 의료 기술에서 점점 더 많은 견인력을 얻고 있습니다. 이 연구는 건강 모니터링, 진단, 질병 관리에 음성 기반 분석을 활용하는 스타트업의 역할이 확대되고 있음을 강조하며, 디지털 건강 전망에서 음성 바이오마커의 변혁적 잠재력을 강조하고 있습니다.

시장 성장 촉진요인

만성질환 유병률 증가

주요 시장 이슈

프라이버시 및 데이터 보안에 대한 우려

주요 시장 동향

원격 의료 및 원격 환자 모니터링

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 음성 바이오마커 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 테크닉별(Frequency, Amplitude, Error Rate, Vocal Rise or Fall Time, Phonation Time, Vocal Tremor, Pitch, 기타)
  • 적응증별(정신 질환, 호흡기 질환, 심혈관 질환, 외상성 뇌손상(TBI), 신경 질환, 기타)
  • 최종사용자별(병원 및 진료소, 외래 진료 센터, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵
  • 기술별
  • 적응증별
  • 최종사용자별
  • 지역별

제5장 아시아태평양의 음성 바이오마커 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 기술별
  • 적응증별
  • 최종사용자별
  • 국가별
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 호주
  • 일본
  • 한국

제6장 유럽의 음성 바이오마커 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 스페인
  • 이탈리아
  • 영국

제7장 북미의 음성 바이오마커 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제8장 남미의 음성 바이오마커 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제9장 중동 및 아프리카의 음성 바이오마커 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이집트

제10장 시장 역학

• 성장 촉진요인
• 과제

제11장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 인수합병(M&A)

제12장 세계의 음성 바이오마커 시장 : SWOT 분석

제13장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• IBM Corporation
• Boston Technology Corporation
• EVOCAL Health
• Audio Profiling
• Cogito Corporation
• Kintsugi
• Sharecare Inc.
• Microtest Health
• Sonde Health
• AudEERING

제15장 전략적 제안

제16장 리서치사에 대해 & 면책사항

영문목차

Global Vocal Biomarker Market was valued at USD 2.01 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 9.32% through 2030. The Global Vocal Biomarker Market is a rapidly emerging and dynamic sector within the healthcare and technology industries, driven by the innovative integration of voice analysis and artificial intelligence. Vocal biomarkers are a revolutionary concept that leverages the wealth of information embedded in our voices to diagnose, monitor, and predict various medical conditions. This market is gaining substantial traction due to its non-invasive nature and the potential to transform healthcare by providing early detection and personalized treatment solutions. For instance, according to an article published in the National Library of Medicine titled "Voice as a Biomarker in Health-Tech: Mapping the Evolving Landscape of Voice Biomarkers in the Start-Up World," the use of voice as a biomarker is gaining traction in health technology. The study highlights the growing role of startups in leveraging voice-based analytics for health monitoring, diagnosis, and disease management, emphasizing the transformative potential of vocal biomarkers in the digital health landscape.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a significant driving force behind the burgeoning Global Vocal Biomarker Market. Chronic diseases, such as diabetes, cardiovascular conditions, respiratory disorders, and mental health issues, have reached epidemic proportions worldwide. These conditions often require continuous monitoring, early detection, and personalized interventions to manage effectively. Vocal biomarkers, which harness the power of voice analysis and artificial intelligence, have emerged as a non-invasive and cost-effective solution to address the challenges posed by these chronic health issues. For instance, non-communicable diseases (NCDs), including cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases, are long-lasting and non-transmissible, posing a growing global health challenge. In 2019, NCDs caused 12 million deaths in the Western Pacific Region. Despite earlier progress in reducing premature deaths, new risk factors and changing environments have reversed gains in some countries over the past decade. Additionally, in 2021, neurological conditions accounted for 443 million disability-adjusted life years (DALYs) lost to illness, disability, and premature death, surpassing cardiovascular diseases as the leading contributor to the global disease burden.

Vocal biomarkers offer a unique advantage in the management of chronic diseases by enabling the detection of subtle changes in a person's voice over time. For instance, in diabetes management, vocal biomarkers can aid in the remote monitoring of glucose levels and associated fluctuations. This innovative approach provides an unobtrusive way for individuals to track their health status, reducing the need for frequent clinic visits and empowering patients to take charge of their well-being.

Key Market Challenges

Privacy and Data Security Concerns

The Global Vocal Biomarker Market holds great promise in the field of healthcare, offering innovative solutions for the diagnosis and monitoring of various medical conditions through the analysis of voice data. However, its growth is significantly hindered by pressing privacy and data security concerns that cast a shadow over the adoption of this technology.

One of the foremost challenges that vocal biomarkers face is the handling and safeguarding of sensitive voice data. Voice recordings carry highly personal and identifiable information, making them a potential goldmine for malicious actors if not adequately protected. Patients and healthcare providers alike are rightfully concerned about the potential misuse or unauthorized access to such data.

Implementing robust encryption measures is fundamental to ensuring the security of voice data. Utilizing end-to-end encryption and other state-of-the-art data protection techniques can safeguard voice recordings throughout their collection, transmission, and storage.

Patients should have control over their voice data, and informed consent should be obtained before recording and analyzing their voices. Users must be aware of how their data will be used and have the ability to revoke access at any time.

Key Market Trends

Telemedicine and Remote Patient Monitoring

Telemedicine and remote patient monitoring are emerging as powerful drivers behind the surge of the Global Vocal Biomarker Market. These healthcare trends, accelerated by the COVID-19 pandemic, are reshaping the way medical services are delivered and are creating a favorable environment for the adoption of vocal biomarkers.

Telemedicine, which involves providing medical consultations and healthcare services remotely, has gained immense popularity due to its convenience and the imperative to maintain social distancing during the pandemic. Patients now have the option to record their voices using smartphones or specialized devices and share this data with healthcare providers for analysis. Vocal biomarkers, through their non-invasive nature, enable patients to actively participate in their own healthcare, allowing for the remote monitoring of various medical conditions, from mental health assessments to the diagnosis and monitoring of chronic diseases.

Key Market Players

• IBM Corporation
• Boston Technology Corporation
• EVOCAL Health
• Audio Profiling
• Cogito Corporation
• Kintsugi
• Sharecare Inc.
• Microtest Health
• Sonde Health
• AudEERING

Report Scope:

In this report, the Global Vocal Biomarker Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vocal Biomarker Market, By Technique:

• Frequency
• Amplitude
• Error Rate
• Vocal Rise or Fall Time
• Phonation Time
• Vocal Tremor
• Pitch
• Others

Vocal Biomarker Market, By Indication:

• Psychiatric Disorders
• Respiratory Disorders
• Cardiovascular Disorders
• Traumatic Brain Injury (TBI)
• Neurological disorders
• Other

Vocal Biomarker Market, By End User:

• Hospitals & clinics
• Ambulatory Surgical Services
• Others

Vocal Biomarker Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vocal Biomarker Market.

Available Customizations:

Global Vocal Biomarker Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Vocal Biomarker Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Technique (Frequency, Amplitude, Error Rate, Vocal Rise or Fall Time, Phonation Time, Vocal Tremor, Pitch, Others)
  • 4.2.2. By Indication (Psychiatric Disorders, Respiratory Disorders, Cardiovascular Disorders, Traumatic Brain Injury (TBI), Neurological disorders, Other)
  • 4.2.3. By End-User (Hospitals & Clinics, Ambulatory care Centers, Others)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Technique
  • 4.3.2. By Indication
  • 4.3.3. By End-User
  • 4.3.4. By Region

5. Asia Pacific Vocal Biomarker Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technique
  • 5.2.2. By Indication
  • 5.2.3. By End-User
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Vocal Biomarker Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Technique
      • 5.3.1.2.2. By Indication
      • 5.3.1.2.3. By End-User
  • 5.3.2. India Vocal Biomarker Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Technique
      • 5.3.2.2.2. By Indication
      • 5.3.2.2.3. By End-User
  • 5.3.3. Australia Vocal Biomarker Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Technique
      • 5.3.3.2.2. By Indication
      • 5.3.3.2.3. By End-User
  • 5.3.4. Japan Vocal Biomarker Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Technique
      • 5.3.4.2.2. By Indication
      • 5.3.4.2.3. By End-User
  • 5.3.5. South Korea Vocal Biomarker Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Technique
      • 5.3.5.2.2. By Indication
      • 5.3.5.2.3. By End-User

6. Europe Vocal Biomarker Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technique
  • 6.2.2. By Indication
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Vocal Biomarker Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technique
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By End-User
  • 6.3.2. Germany Vocal Biomarker Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technique
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By End-User
  • 6.3.3. Spain Vocal Biomarker Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technique
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By End-User
  • 6.3.4. Italy Vocal Biomarker Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Technique
      • 6.3.4.2.2. By Indication
      • 6.3.4.2.3. By End-User
  • 6.3.5. United Kingdom Vocal Biomarker Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Technique
      • 6.3.5.2.2. By Indication
      • 6.3.5.2.3. By End-User

7. North America Vocal Biomarker Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technique
  • 7.2.2. By Indication
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Vocal Biomarker Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technique
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By End-User
  • 7.3.2. Mexico Vocal Biomarker Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technique
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By End-User
  • 7.3.3. Canada Vocal Biomarker Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technique
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By End-User

8. South America Vocal Biomarker Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technique
  • 8.2.2. By Indication
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Vocal Biomarker Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technique
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By End-User
  • 8.3.2. Argentina Vocal Biomarker Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technique
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By End-User
  • 8.3.3. Colombia Vocal Biomarker Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technique
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By End-User

9. Middle East and Africa Vocal Biomarker Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technique
  • 9.2.2. By Indication
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Vocal Biomarker Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technique
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By End-User
  • 9.3.2. Saudi Arabia Vocal Biomarker Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technique
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By End-User
  • 9.3.3. UAE Vocal Biomarker Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technique
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By End-User
  • 9.3.4. Egypt Vocal Biomarker Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Technique
      • 9.3.4.2.2. By Indication
      • 9.3.4.2.3. By End-User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Vocal Biomarker Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. IBM Corporation
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Boston Technology Corporation
• 14.3. EVOCAL Health
• 14.4. Audio Profiling
• 14.5. Cogito Corporation
• 14.6. Kintsugi
• 14.7. Sharecare Inc.
• 14.8. Microtest Health
• 14.9. Sonde Health
• 14.10.AudEERING

15. Strategic Recommendations

16. About Us & Disclaimer